Sector ratings Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Berne S.E.
03/09/2026
|
5-day change | 1st Jan Change | ||
| 233.98 CHF | +0.82% |
|
-3.43% | - |
| 21/08 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 20/08 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 5.03TCr | AAA | |||||||
| 4.52TCr | - | B | - | - | ||||
| 4.47TCr | AAA | |||||||
| 4.12TCr | - | |||||||
| 3.31TCr | A | |||||||
| 1.78TCr | - | - | - | - | ||||
| 1.66TCr | BBB | |||||||
| 1.48TCr | AA | |||||||
| 1.4TCr | AA | |||||||
| 1.26TCr | AAA | |||||||
| 1.14TCr | AA | |||||||
| 1.17TCr | A | - | ||||||
| 1.08TCr | AA | |||||||
| 1.08TCr | - | BBB | - | - | ||||
| 966.03Cr | - | A | - | - | ||||
| 1.01TCr | AA | - | ||||||
| 991.58Cr | - | B | - | - | ||||
| 975.19Cr | - | BBB | - | - | ||||
| 962.86Cr | BB | - | ||||||
| Average | 2.02TCr | A | |||||||
| Weighted average by Cap. | A |
Select your edition
All financial news and data tailored to specific country editions
